Occupational Allergic Rhinoconjunctivitis to Tachypleus Amoebocyte Lysate: A Case Report
Horseshoe crabs, ancient marine arthropods belonging to the genera Limulus, Tachypleus, and Carcinoscorpius, play a critical role in biomedical applications. Amoebocyte lysate, derived from the blood cells of these crabs, is essential for endotoxin detection in pharmaceuticals and medical devices. Two primary variants exist: Limulus amoebocyte lysate (LAL) and Tachypleus amoebocyte lysate (TAL). While invaluable for ensuring product safety, these reagents pose occupational health risks, particularly allergic reactions among laboratory personnel. This report details a confirmed case of occupational allergic rhinoconjunctivitis induced by TAL exposure, illustrating diagnostic approaches and management strategies.
Clinical Presentation
A 32-year-old female pharmacy laboratory technician presented with a six-month history of recurrent nasal itching, congestion, sneezing, clear rhinorrhea, and itchy eyes. Symptoms consistently emerged within minutes of preparing TAL solutions for endotoxin testing. The patient had worked with TAL since 2006, with no prior history of atopic diseases or allergies. Physical examination during symptomatic episodes revealed conjunctival erythema, nasal mucosal swelling, and clear nasal discharge. No systemic symptoms, such as dyspnea or urticaria, were reported.
Diagnostic Evaluation
Skin Prick Test (SPT)
A skin prick test using TAL (0.25 EU: 0.1 mL/ampule) produced an immediate positive reaction characterized by a 19 mm × 11 mm wheal and 47 mm × 78 mm erythema. No late-phase reaction occurred. A non-atopic control subjected to the same test showed no response (Figure 1A).
Realistic and Nasal Provocation Testing (NPT)
To confirm causality, realistic and nasal provocation challenges were conducted. In the realistic challenge, the patient dissolved six TAL ampules in a clinical setting. Nasal airflow resistance and pulmonary function were measured at baseline, 30 minutes, and 4 hours post-exposure. Within six minutes, she developed rhinoconjunctivitis symptoms, accompanied by a 97% increase in nasal resistance at 30 minutes compared to baseline. Pulmonary function remained normal.
In a separate nasal provocation test, TAL solution was applied directly to the inferior turbinate via filter paper. Immediate nasal itching progressed to severe rhinorrhea, congestion, and sneezing within five minutes. Total Nasal Symptom Scores (TNSS) reached seven points (rhinorrhea: 2, obstruction: 2, sneezing: 1, nasal itch: 2). Nasal resistance measurements were unattainable due to profound obstruction. The control participant exhibited no reactions.
Immunoblotting Analysis
Serum IgE reactivity to TAL was evaluated via immunoblotting. The patient’s serum recognized two distinct TAL protein bands at 20 kDa and 185 kDa (Figure 1B). No immunoreactive bands were detected in control sera, confirming the specificity of IgE-mediated sensitization to TAL components.
Diagnosis and Management
A definitive diagnosis of occupational allergic rhinoconjunctivitis to TAL was established based on clinical history, positive SPT/NPT results, and IgE serology. The primary management strategy involved strict avoidance of TAL exposure. When contact was unavoidable, the use of biosafety cabinets and N95 respirators was recommended. Follow-up assessments revealed a significant reduction in symptoms after implementing these precautions.
Pathophysiological and Occupational Insights
The identification of 20 kDa and 185 kDa IgE-reactive proteins in TAL highlights novel allergenic components distinct from those previously reported in LAL. While a 1992 case implicated LAL in similar allergic reactions, this report is the first to characterize TAL-specific occupational allergy with molecular evidence. The pathophysiology likely involves aerosolized TAL proteins triggering type I hypersensitivity reactions in sensitized individuals.
Occupational settings involving frequent preparation of TAL solutions—particularly without adequate ventilation or personal protective equipment—increase inhalation exposure risks. The delayed recognition of symptoms in this case (occurring after 14 years of exposure) underscores the importance of vigilance in monitoring long-term laboratory personnel.
Implications for Workplace Safety
This case emphasizes the necessity of occupational health protocols for handling TAL and LAL. Key recommendations include:
- Engineering Controls: Use of biosafety cabinets to minimize aerosol dispersion.
- Personal Protective Equipment (PPE): Respirators (e.g., N95 masks) and gloves during reagent preparation.
- Health Surveillance: Regular symptom screening and IgE testing for exposed workers.
- Alternative Reagents: Exploration of synthetic endotoxin detection methods to reduce reliance on animal-derived lysates.
Conclusion
Occupational allergic rhinoconjunctivitis to TAL represents an underrecognized hazard in pharmaceutical and biomedical laboratories. This case demonstrates the utility of SPT, provocation testing, and immunoblotting in confirming occupational allergies. The identification of 20 kDa and 185 kDa IgE-reactive proteins advances understanding of TAL-specific sensitization. Proactive preventive measures, including exposure control and worker education, are critical to mitigating risks in high-exposure environments.
DOI: 10.1097/CM9.0000000000000689
Was this helpful?
0 / 0